• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Infection

AstraZeneca is pleased to present healthcare professionals with a variety of renal resources for your informational purposes.
The educational materials are intended to provide disease-state information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Continuing Education
  4. Pipeline

May 19 -22, 2022

European Renal Association-European Dialysis and Transplant Association congress (ERA-EDTA) 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

April 6-10, 2022

National Kidney Foundation (NKF) 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

April 6- 10, 2021

National Kidney Foundation (NKF) 2021

Explore AstraZeneca Scientific Materials Visit Congress Site
  • EVUSHELD™ (tixagevimab co-packaged with cilgavimab) injection, for intramuscular use. Authorized for Emergency Usage Only

e-Learning

Clinical Issues in COVID-19: Debates and Discussions About Monoclonal Antibody Therapies

Integritas Communications

15-Oct-2021 to 15-0ct-2022

A review oT the stratification of pattents with CoviD-19 based on isks of adisease progression, Current evidence and regulatory status Tor ant-SAHS- Cov-2 monoclonal antibodies, and how to utilize the treatment options.

Learn More

e-Learning

Activity 1: Current Evidence for Anti-SARS-CoV-2 Monoclonal Antibodies for Pre-Exposure Prophylaxis

Integritas Communications

25-Mar-2022 to 25-Mar-2023

online multimedia activity

Learn More

e-Learning

Activity 2: Immunocompromised Patients and COVID-19 Risks

Integritas Communications

01-Apr-2022 to 01-Apr-2023

online multimedia activity

Learn More

e-Learning

Activity 3: Point-of-Care Use of Anti-SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis

Integritas Communications

07-Apr-2022 to 07-Apr-2023

online multimedia activity

Learn More

e-Learning

Do You Know How To Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis (PrEP) for Your Post- Transplant Patients? Test Your Knowledge

Johns Hopkins University

05-Jun-2022 to 04-Jul-2023

1.0 credit hour learner-interacive online enduring activity & point-of-care practice tools

Learn More

e-Learning

COVID-19 Monoclonal Antibody Toolkit

Society of Infectious Diseases Pharmacists

04-Apr-2022 to 31-Mar-2023

Self-guided educational toolkit

Learn More

Redirecting...

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice